Join now to get access to this content and more.
Become a SOAP member and have access to our benefits.
- 2020 SOAP Virtual Meeting Series Videos
- For Review: SOAP Consensus Statement on Neuraxial Procedures in Thrombocytopenic Parturients
- Sample Centers of Excellence Applications
- ASA Corner
- SOAP Policy and Procedure Manual (P&P Manual)
- SOAP Expert Opinions
- SOAP's Learning Modules
- 2019 Annual Meeting Lecture Videos
- December 2018 - SOAP Unofficial Guide to ASA Committees Webinar
- Submit a Position
- View Job Postings
- Previous Meeting Archives
- Previous Meeting Abstract Search
- CMS Guidelines
- Member Benefits
- Newsletter Clinical Articles
- ACOG Documents
- Search our Patient Safety Archive
- Ask SOAP a Question
- Global Health Opportunities
- And more…
Perioperative Management of a Parturient with Uncorrected Chiari Malformation on Buprenorphine Therapy
Abstract Number: 232
Abstract Type: Case Report/Case Series
Uncorrected Chiari malformation poses a peridelivery challenge for patients as both Valsalva maneuvers and dural puncture confer a theoretical risk of tonsillar herniation. Buprenorphine therapy further complicates perioperative pain management in parturients, necessitating multidisciplinary communication and planning. We present the case of a 25 year-old primiparous woman on buprenorphine with Valsalva-induced headaches, who was recently diagnosed bilateral cerebellar tonsillar ectopia extending up to eight millimeters below the foramen magnum, consistent with type I Chiari malformation.
The goals of her delivery and anesthetic plan included:
a. Minimizing Valsalva maneuvers
b. Avoiding dural puncture
c. Maximizing multimodal analgesia
A multidisciplinary team was established to weigh the risks and benefits of the various delivery options available. After consideration of the theoretical risks of dural puncture with neuraxial anesthesia and the patient's probable inability to tolerate assisted vaginal delivery without neuraxial anesthesia, primary cesarean delivery under general anesthesia was planned and performed at 39 weeks without complication.
Postoperative pain management was complicated by the patient's daily use buprenorphine and alprazolam, and was without the benefit of neuraxial narcotic. Therefore, a multimodal approach to analgesia was planned, with intraoperative placement of a transversus abdominis plane peripheral nerve block under ultrasound-guidance (40 milliliters of half-percent bupivacaine), intravenous hydromorphone (6 milligrams), intravenous ketorolac (30 milligrams), and postoperative intravenous hydromorphone patient-controlled analgesia (PCA). The patient's course was complicated by somnolence, induced by third-party triggering of her PCA, and significant bradyarrhythmia, thought to be secondary to supratherapeutic doses of outpatient buprenorphine and alprazolam. Ultimately, the patient received low dose intravenous ketamine (two doses of 10 milligrams each, given over twenty minutes) with satisfactory analgesia and hemodynamics.
This case highlights the benefits of a multidisciplinary and multimodal approach to the perioperative management of parturients with multiple comorbidities.
Chantigian RC, et. al. Chiari I malformation in parturients. J Clin Anesth. 2002; 14: 201-5.
Barton JJ et. al. Oscillopsia and horizontal nystagmus with accelerating slow phases following lumbar puncture in the Arnold-Chiari malformation. Ann Neurol. 1993; 33: 418-21.
Angst M.S. et. al. Ketamine for managing perioperative pain in opioid-dependent patients with chronic pain Anesth. 2010;113: 514-5.
Urban MK, et. al. Ketamine as an adjunct to postoperative pain management in opioid tolerant patients after spinal fusions: a prospective randomized trial. HSS J. 2008; 4: 62-5.